You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Post-transplant Cytoxan

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Peripheral Blood Stem Cell Transplant
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Mar 27, 2023

Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

Recruiting
  • Primary Immune Deficiency Disorder
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University
Oct 20, 2022

Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

Recruiting
  • Hematologic Malignancy
  • Myeloid Malignancy
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Nov 7, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)

Active, not recruiting
  • Graft Versus Host Disease
  • Hematopoietic/Lymphoid Cancer
  • fludarabine phosphate
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Aug 5, 2022

Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, Bortezomib)

Recruiting
  • Graft-versus-host Disease
  • New York, New York
    NYU Langone Health
Mar 24, 2022

Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)

Recruiting
  • Graft Vs Host Disease
  • New York, New York
    NYU Langone Health
Nov 10, 2022

Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +6 more
  • (no location specified)
Dec 8, 2021

Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)

Recruiting
  • Hematological Malignancies
  • Total Body Irradiation
  • +6 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 4, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Acute Myeloid Leukemia Trial in Duarte (procedure, drug, biological, other, radiation)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Jun 8, 2022

Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Bone Marrow Hematopoeitic Cell Transplant (HCT)
  • +9 more
  • (no location specified)
Sep 27, 2021

Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor Trial in Saint Louis (Metronomic Cyclophosphamide, Thalidomide)

Recruiting
  • Glioma
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 22, 2021

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Anemia, Sickle Cell Trial in New York (Siplizumab, Exchange Transfusion, Total Body Irradiation)

Recruiting
  • Anemia, Sickle Cell
  • New York, New York
    Columbia University Irving Medical Center
Oct 9, 2023

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Cyclophosphamide, Tacrolimus,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Maywood, Illinois
    Loyola University Medical Center
Apr 22, 2021

Hematopoietic and Lymphoid Cell Tumor, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +13 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 8, 2022

Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)

Not yet recruiting
  • Acute Leukemia
  • Rifaximin with allogeneic stem cell transplant
  • Allogeneic stem cell transplant
  • (no location specified)
Sep 21, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +16 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 1, 2022

Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

Active, not recruiting
  • Acute Leukemia
  • +14 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

Recruiting
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 25, 2023

DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,

Recruiting
  • DOCK8 Deficiency
  • Reduced-intensity hematopoietic stem cell
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • (no location specified)
Oct 18, 2022

Acute Myeloid Leukemia, MDS Trial in Nashville, San Antonio (biological, drug, procedure)

Terminated
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • rivogenlecleucel
  • +3 more
  • Nashville, Tennessee
  • +1 more
Nov 11, 2020